As Trump said to the executives: Our trade policy will prioritize that foreign countries pay their fair share for US manufactured drugs, so [that] our drug companies have greater financial resources to accelerate the development of new cures. And once again, the industry was receptive.   As White House Press Secretary Sean Spicer tweeted later: And in another tweet, PhARMAâ€™s Ubl declared the enthusiastic assent of the whole group:   We believe @POTUS agenda on taxes, trade  regulations could create 350, 000 American jobs over 10 years due to biopharma industry growth.   